Denise Scots-Knight, Chief Executive Officer at Mereo BioPharma Group plc (MREO), sold 177,314 shares at $4.47 ($763K) on 2024-09-12, disclosed to the SEC on 2024-09-16.
Open-market sale of $763k MREO by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.47 | 28,611 | $128K | 16.8% |
| 2 | $4.47 | 28,611 | $128K | 16.8% |
| 3 | $4.22 | 60,046 | $253K | 33.2% |
| 4 | $4.22 | 60,046 | $253K | 33.2% |
| Total | $4.30 avg | 177,314 | $763K | 100% |